The Future of Sex Medicine

Sooner or later every guy deals with some type of mechanical “male-function,” such as premature ejaculation (PE) or erectile dysfunction (ED). Being quick on the trigger might work great in Westerns, but it’s not such a benefit in between the sheets.

Likewise, the laws of physics are a little skewed in the bedroom, where what should go up doesn’t always stay up.

All this week at Good in Bed, we’re talking about male sexual health.

If you’re dealing with PE or ED, you’re not alone. They’re two of the most common male sexual health issues. Despite their frequency, though, these conditions remain undertreated. While some men with ED have found temporary help through drugs like Viagra, Levitra and Cialis, it’s estimated that more than half of them won’t continue using the drug for very long.

Meanwhile, there’s been little to no help for men with PE.

Read more: http://www.foxnews.com/health/2011/01/13/future-sex-medicine

 

Print Friendly

A “Miracle” Drug called Aspirin

If you take aspirin, you’ve got a pain reliever, heart attack preventer and possible cancer preventer rolled into one tablet. You might think that whoever invented aspirin is a genius, but the truth is humans have been using its natural equivalent for thousands of years.

“Aspirin is one of those things that, long before there were ever clinical trials or any kind of scientific knowledge, people figured out, ‘Hey, I feel better when I take this substance,’ ” said Dr. Karol Watson, assistant professor of cardiology at the David Geffen School of Medicine at the University of California, Los Angeles.

The drug has been making headlines because a study in the Lancet recently found that a daily aspirin appeared to lower the risk of cancer by at least 20% during a 20-year period. That’s based on data from more than 25,000 patients and builds on earlier findings that aspirin may lower the risk of colorectal cancer. The research has limitations and is not definitive proof, but it does add another benefit to an ancient remedy that has been called a miracle drug.

“There are no countries in which it is unknown, unappreciated, or unavailable,” the late medical writer Berton Roueché wrote in 1955, in an article later published in the anthology “The Medical Detectives.”

For full story, click here.

Print Friendly

Mindful and Awakening Relationships Workshop

The KL Buddhist Mental Health Association is organising the Mindful and Awakening Relationships (MARS) workshop at the Turning Point Integrated Wellness Sdn. Bhd. in Puchong in October 2011. This workshop will be facilitated by Dr. Tan Eng Kong (see his profile below) from the Metta Clinic in Sydney, Australia.

Note that there is an early bird discount before 17 May, 2011. The regular fee is RM600 for this two-day workshop but you can save a tidy RM200 if you register before 17 May as early birds pay only RM400. Since this is a relationship workshop, I would suggest that you see this as a way to practice commitment.

You can download the brochure for more details and to register.

Click here to download the MARS2011 brochure.

This workshop is limited to 40 pax only, first come first serve basis, so book your place before it is filled up. Continue reading

Print Friendly

Walking could ward off dementia

Elderly people who get about by walking are less likely to suffer mental decline or even dementia, a study says.

Brain scans revealed that older people walking between six and nine miles a week appeared to have more brain tissue in key areas.

The Pittsburgh University study of 299 people suggested they had less “brain shrinkage”, which is linked to memory problems.

The research was reported in the journal Neurology.

For the full report, click here.

Print Friendly

CCR saves more lives than CPR

For the past 40 years, CPR has been composed of two things—rescue breaths and chest compressions—and this formula for cardiac survival can revive around 25 percent of patients without a pulse. However, emerging evidence suggests there may be a more effective protocol for resuscitation that can save even more lives, and it’s simpler than traditional CPR.

Cardiocerebral resuscitation, or CCR, differs from CPR in that for the first 5 to 10 minutes after cardiac arrest, a rescuer does not breathe for the patient at all. Instead, the focus shifts to performing unrelenting chest compressions at a rate of 100 per minute. One clinical trial in Wisconsin showed this technique saved 30 percent more lives when compared with traditional CPR. Better yet, patients who receive CCR instead of CPR were found to be 24 percent more likely to be neurologically intact upon release from the hospital.

For the full story, click here.

Print Friendly

Mindfulness-based Stress & Anxiety Reduction

M-STAR (Mindfulness-based Stress & Anxiety Reduction) is a mindfulness-based stress management program specially tailored for relaxation and wellness.

It is based on state-of-the-art research in mindfulness and positive psychology. The program will be conducted in didactic and experiential approach to ensure maximum learning and benefits.

It is divided in two parts – M-STAR I (4 weeks) and M-STAR II (4 weeks), with weekly 2-hour meetings and daily exercises and a month break in between M-STAR I and M-STAR II for consolidation of practice.

M-STAR will be conducted at Turning Point Wellness Centre by Dr. Phang Cheng Kar (M.D.). For further information, kindly Download Brochure

Print Friendly

Some anti-hypertensive drugs linked to cancer risk

Angiotensin-receptor blockers (ARBs) have been associated with a modest increased risk of developing cancer, in a new meta-analysis. Specifically, there was a significant 25% increased risk of lung cancer with the use of this drug class, but no link to breast or prostate cancer was seen.

“This is a modest increase, similar to that seen with passive smoking; it’s not a massive increase,” lead author of the study, Dr Ilke Sipahi (University Hospitals Case Medical Center, Cleveland, OH), told heartwire.

Nevertheless, this is the first time such an association has been made, he said. And although the number needed to treat to cause one excess cancer was calculated to be 105 patients for four years, meaning the risk for the individual patient is not huge, “given the millions of patients on these drugs, this is an important number, because it gives us an idea of potentially how many excess cancers could be caused by these medications. On a population level, I think these are very concerning signals.”

For the complete story, click here.

Print Friendly

Vitamin B delays onset of Alzheimer’s disease

A new study suggests high doses of B vitamins may halve the rate of brain shrinkage in older people experiencing some of the warning signs of Alzheimer’s disease.

Brain shrinkage is one of the symptoms of mild cognitive impairment, which often leads to dementia.

Researchers say this could be the first step towards finding a way to delay the onset of Alzheimer’s.

Experts said the findings were important but more research was needed.

The study, published in the journal Public Library of Science One, looked at 168 elderly people experiencing levels of mental decline known as mild cognitive impairment.

For the complete story, click here.

Print Friendly

Osteoporosis drug may boost cancer risk

People who take bisphosphonates, or bone-strengthening drugs for osteoporosis, may have a slightly higher risk of developing esophageal cancer, especially if they take them for several years, a study out this week in the British Journal of Medicine finds.

Researchers tracked almost 3,000 people with cancer of the esophagus or throat for eight years and compared them with a group of 15,000 people who did not have the disease. All were over age 40. The scientists found that 90 of the cancer patients had been prescribed the bone-building drugs, while 345 people in the larger group were taking the medication.

For details, click here.

Print Friendly